Bui Thi Hong Nhung, Le Thien Bao Long, Nguyen Viet Hung, Nguyen Khac Tiep, Dang Thai Hoang, Do Huy Hoang, Tran Phuong Thao

Main Article Content

Abstract

Tetrazole derivatives are a prominent class of heterocycles that hold significant value in medicinal chemistry and drug design. Their importance stems from their bioisosteric resemblance to carboxylic acid and amide moieties and their favorable metabolic stability and other beneficial physicochemical properties. In light of this, novel derivatives bearing the (pyridine-2-yl)tetrazol scaffold were synthesized with the presence of acid, ester and amide moieties and evaluated for their inhibitory effects on the enzyme acetylcholinesterase (AChE). Through a three-step synthesis reaction initiated with 2-pyridine carbonitrile, compound IV was successfully obtained with II and III as the intermediates. All substances II - III - IV demonstrated inhibitory activity against the enzyme acetylcholinesterase. Notably, substance IV exhibited the highest percentage of inhibition, achieving 23,7 % at a concentration of 75 µM. Based on molecular docking simulations, compounds containing stronger nucleophilic substituents exhibit more robust AChE enzyme inhibitory activity due to a greater abundance of hydrogen bonds. This drug-likeness simulation and ADME prediction highlight the potential of tetrazole derivatives as a promising treatment for Alzheimer's disease.

Keywords: Alzheimer, Acetylcholinesterase, Tetrazol

References

1. Hippius H, Neundörfer G. The discovery of Alzheimer's disease. Dialogues in clinical neuroscience. 2003;5(1):101-8.
2. A. A. 2023 Alzheimer's disease facts and figures. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2023;19(4):1598-695.
3. Sang Z, Wang K, Dong J, Tang L. Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress. European journal of medicinal chemistry. 2022;238:114464.
4. Xu Y, Cheng S, Sussman JL, Silman I, Jiang H. Computational Studies on Acetylcholinesterases. Molecules (Basel, Switzerland). 2017;22(8).
5. Guo Y, Yang H, Huang Z, Tian S, Li Q, Du C, et al. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases. Molecules (Basel, Switzerland). 2020;25(3).
6. Son M, Park C, Rampogu S, Zeb A, Lee KW. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease. International journal of molecular sciences. 2019;20(4).
7. Yu D, Yang C, Liu Y, Lu T, Li L, Chen G, et al. Synthesis and biological evaluation of substituted acetamide derivatives as potential butyrylcholinestrase inhibitors. Scientific reports. 2023;13(1):4877.
8. Neochoritis CG, Zhao T, Dömling A. Tetrazoles via Multicomponent Reactions. Chemical reviews. 2019;119(3):1970-2042.
9. Dişli A, Gümüş M, Önal K, Sarı N, Arslan FJMJoC, Engineering C. New multifunctional agents and their inhibitory effects on the acetyl cholinesterase enzyme. Macedonian Journal of Chemistry and Chemical Engineering. 2018;37(1):21-34.
10. Pandolfi F, De Vita D, Bortolami M, Coluccia A, Di Santo R, Costi R, et al. New pyridine derivatives as inhibitors of acetylcholinesterase and amyloid aggregation. European journal of medicinal chemistry. 2017;141:197-210.
11. Pires DE, Blundell TL, Ascher DBJJomc. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry. 2015;58(9):4066-72.
12. Cheung J, Rudolph MJ, Burshteyn F, Cassidy MS, Gary EN, Love J, et al. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. Journal of Medicinal Chemistry. 2012;55(22):10282-6.